Understanding the pathophysiology of cerebral amyloid angiopathy

Laura Gatti, Francesca Tinelli, Emma Scelzo, Francesco Arioli, Giuseppe Di Fede, Laura Obici, Leonardo Pantoni, Giorgio Giaccone, Paola Caroppo, Eugenio Agostino Parati, Anna Bersano

Research output: Contribution to journalReview articlepeer-review


Cerebral amyloid angiopathy (CAA), one of the main types of cerebral small vessel disease, is a major cause of spontaneous intracerebral haemorrhage and an important contributor to cognitive decline in elderly patients. Despite the number of experimental in vitro studies and animal models, the pathophysiology of CAA is still largely unknown. Although several pathogenic mechanisms including an unbalance between production and clearance of amyloid beta (Aβ) protein as well as ‘the prion hypothesis’ have been invoked as possible disease triggers, they do not explain completely the disease pathogenesis. This incomplete disease knowledge limits the implementation of treatments able to prevent or halt the clinical progression. The continuous increase of CAA patients makes imperative the development of suitable experimental in vitro or animal models to identify disease biomarkers and new pharmacological treatments that could be administered in the early disease stages to prevent irreversible changes and disease progression.

Original languageEnglish
Article number3435
JournalInternational Journal of Molecular Sciences
Issue number10
Publication statusPublished - May 2 2020


  • Amyloid beta protein
  • Biomarkers
  • Cerebral amyloid angiopathy
  • Dementia
  • Neuroimaging
  • Outcome
  • Pathophysiology
  • Small vessel disease
  • Treatment

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Understanding the pathophysiology of cerebral amyloid angiopathy'. Together they form a unique fingerprint.

Cite this